PATENT CLAIM ANALYSIS

Application Number: 16081062
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "274100"]

Abstract:
The invention features methods and kits use in for preventing and treating vulvovaginal candidiasis (VVC), in particular, recurrent VVC.

Claim (Index 15):
The method of  claim 14 , wherein about 10 to 200 micrograms, about 20 to 100 micrograms, about 30 to 90 micrograms, 4 about 0 to 80 micrograms, about 100 to 300 micrograms, about 150 to 200 micrograms, about 200 to 250 micrograms, about 250 to 300 micrograms, or about 300 micrograms of said Als3 polypeptide is administered.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14234269', '16006526', '14000815', '14680860', '15674569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6739693467724218
- 35 USC 102 Novelty (BERT): 0.5252821096699609
- Combined Prediction Score: 0.6591006230621758
- Mean Citation Score: 236.78651800000003
- Max Citation Score: 294.94412
- Similarity Product: 195.69850336164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test